Showing results (441-450 of 1,241) with videos related to

Sort By:
Pageof 125
Jac-Antimicrobial Resistance|July 5, 2021
CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant EnterobacteralesAmy J Mathers, James S Lewis
Jac-Antimicrobial Resistance|July 5, 2021
The antibiogram: key considerations for its development and utilizationWilliam R Truong, Levita Hidayat, Michael A Bolaris, et al.
Jac-Antimicrobial Resistance|July 5, 2021
Nationwide audit and feedback on implementation of antibiotic stewardship programmes in Norwegian hospitalsBrita Skodvin, June U Høgli, Kirsten Gravningen, et al.
Jac-Antimicrobial Resistance|July 5, 2021
Antibacterial use in the age of SARS-CoV-2Kathleen E Angell, James V Lawler, Angela L Hewlett, et al.
Jac-Antimicrobial Resistance|July 5, 2021
Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitalsR Andrew Seaton, Lesley Cooper, Cheryl L Gibbons, et al.
Jac-Antimicrobial Resistance|July 5, 2021
Comparative activity of posaconazole and systemic azole agents against clinical isolates of filamentous fungi from a global surveillance programmeCecilia G Carvalhaes, Paul R Rhomberg, Michael Pfaller, et al.
Jac-Antimicrobial Resistance|May 9, 2022
Combination of phage therapy and cefiderocol to successfully treat Pseudomonas aeruginosa cranial osteomyelitisPatricia J Simner, Jerald Cherian, Gina A Suh, et al.
Jac-Antimicrobial Resistance|May 9, 2022
Nitrofurantoin and glucose-6-phosphate dehydrogenase deficiency: a safety reviewJudith Recht, Vilada Chansamouth, Nicholas J White, et al.
Jac-Antimicrobial Resistance|July 15, 2021
Erratum to: A retrospective 'real-world' cohort study of azole therapeutic drug monitoring and evolution of antifungal resistance in cystic fibrosisM Di Paolo, L Hewitt, E Nwankwo, et al.
Jac-Antimicrobial Resistance|March 31, 2022
Science communication challenges about antimicrobial resistance in animal agriculture: insights from stakeholdersAndy J King, Dara M Wald, Denise D Coberley, et al.
Pageof 125